Department of Cardiopulmonary Bypass, Shanghai Chest Hospital, Shanghai 200030, China.
Chin Med J (Engl). 2010 Feb 5;123(3):269-73.
For patients with end-stage lung diseases, lung transplantation is the final therapeutic option. Sequential double-lung transplantation is recognized as an established procedure to avoid cardiopulmonary bypass (CPB). But some of the sequential double-lung transplantations require CPB support during the surgical procedure for various reasons. However, conventional CPB may increase the risk of bleeding and early allograft dysfunction. Extracorporeal membrane oxygenation (ECMO) is more advantageous than conventional CPB during the perioperative period of transplantation. Replacing traditional CPB with ECMO is promising for those patients needing cardiopulmonary support during a sequential double-lung transplantation procedure. This study aimed to summarize the preliminary experience of ECMO practice in lung transplantation.
Between November 2002 and October 2008, twelve patients with end-stage lung diseases undergoing sequential double-lung transplantation were subjected to ECMO during the surgical procedure. Eleven patients were prepared for the procedure via transverse thoracostomy (clamshell) and cannulated through the ascending aorta and right atrium for ECMO. The first patient who underwent bilateral thoracotomy for bilateral sequential lung transplantation required emergency ECMO via the femoral artery and vein during the second lung implantation. The Medtronic centrifugal pump and ECMO package (CB1V97R1, Medtronic, Inc., USA) were used for all of the patients.
During ECMO, the blood flow rate was set between 1.8 - 2.0 L x m(-2) x min(-1) to keep hemodynamic and oxygen saturation stable; colloid oncotic pressure was maintained at more than 18 mmHg with albumin and hematocrit (HCT) kept at 28% or more. Two patients died early in this series and the other 10 patients were weaned from ECMO successfully. The duration of ECMO was 1.38 - 67.00 hours, and postoperative intubation was 10.5 - 67.0 hours.
As an established technique of cardiopulmonary support, ECMO is helpful to keep hemodynamics stable, while reducing risk factors such as ischemia-reperfusion injury, anticoagulation requirement and systemic inflammatory response for sequential double-lung transplantation compared with conventional CPB.
对于终末期肺部疾病患者,肺移植是最终的治疗选择。序贯双肺移植已被公认为避免体外循环(CPB)的一种既定方法。但由于各种原因,有些序贯双肺移植在手术过程中需要 CPB 支持。然而,传统的 CPB 可能会增加出血和早期移植物功能障碍的风险。体外膜氧合(ECMO)在移植围手术期比传统 CPB 更具优势。对于那些在序贯双肺移植过程中需要心肺支持的患者,用 ECMO 替代传统 CPB 是有希望的。本研究旨在总结 ECMO 在肺移植中的初步经验。
2002 年 11 月至 2008 年 10 月,12 例终末期肺部疾病患者接受序贯双肺移植,手术过程中进行 ECMO。11 例患者通过横断胸骨(蛤壳)准备手术,并通过升主动脉和右心房插管进行 ECMO。第一例接受双侧开胸双侧序贯肺移植的患者,在第二次肺植入时需要通过股动脉和静脉进行紧急 ECMO。所有患者均使用美敦力离心泵和 ECMO 套件(CB1V97R1,美敦力公司,美国)。
在 ECMO 期间,将血流速度设定在 1.8-2.0 L x m(-2) x min(-1) 之间,以保持血流动力学和氧饱和度稳定;胶体渗透压保持在 18mmHg 以上,白蛋白和血细胞比容(HCT)保持在 28%或以上。本系列中有 2 例患者早期死亡,其余 10 例患者成功脱离 ECMO。ECMO 持续时间为 1.38-67.00 小时,术后插管时间为 10.5-67.0 小时。
作为一种已建立的心肺支持技术,ECMO 有助于保持血流动力学稳定,同时与传统 CPB 相比,减少缺血再灌注损伤、抗凝要求和全身炎症反应等危险因素,为序贯双肺移植提供帮助。